Welcome to our dedicated page for BIO-key International news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.
BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.
Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.
BIO-key (NASDAQ: BKYI) will present at the DealFlow Discovery investor conference on Jan 28–29, 2026 at the Borgata hotel in Atlantic City, New Jersey.
CEO Mike DePasquale will deliver a presentation and be available for 1-on-1 meetings; presentation details will be posted on the conference website in January. Institutional investors, family offices and high-net-worth investors may register to attend at no cost via the DealFlow Discovery registration page.
BIO-key (NASDAQ: BKYI) will participate in the 2025 Gartner Identity & Access Management Summit: North America, December 8-10 in Grapevine, TX, exhibiting at Booth 236. The company will demonstrate its passwordless, phoneless, tokenless authentication portfolio including identity-bound biometrics, phishing-resistant MFA alternatives, and cost-effective IAM modernization aimed at reducing credential theft, support costs, and friction while supporting Zero Trust adoption.
BIO-key will engage IAM leaders across finance, healthcare, government, education, and manufacturing to discuss deployment use cases and challenges.
BIO-key (NASDAQ: BKYI) announced a strategic partnership with SAVIS Group to localize and deliver BIO-key’s identity and biometric authentication solutions across Vietnam, effective Nov 17, 2025. SAVIS Group will act as an authorized distributor, providing localized pre-sales, deployment, and technical support through its enterprise ecosystem.
Products to be offered include PortalGuard, Passkey:YOU (FIDO2), PIN:You, WEB-key, identity-bound biometrics, and certified scanners PIV-Pro and EcoID III.
BIO-key (Nasdaq: BKYI) reported Q3 2025 results and held an investor call on November 14, 2025.
Key Q3 metrics: revenue $1,548,706 (down from $2,144,804 a year ago), gross margin 77%, and net loss $964,849 (or $0.15 per share). Balance sheet at September 30, 2025 included $2.04M cash and $3.75M total current assets. The company launched the EcoID III (FAP 20) fingerprint scanner, secured a large Middle East defense deployment, shipped $134,000 in follow-on orders, and expects 2025 full-year revenue of $6.5–$7.0M. Subsequent financing included a $3.1M warrant exercise on October 27, 2025 and remaining notes outstanding of $675,000.
BIO-key (NASDAQ: BKYI) announced a strategic partnership with Dubai-headquartered VaporVM on November 12, 2025 to expand distribution of BIO-key’s identity and biometric solutions across the Middle East and Africa. VaporVM will integrate and promote BIO-key’s PortalGuard IAM platform, Passkey:YOU (FIDO2 passwordless), PIN:You, WEB-key biometric engine, identity-bound biometrics, and certified scanners, and provide local deployment, partner enablement, and technical support. The collaboration targets enterprises and public-sector organizations operating on AWS, Azure, and GCP, aiming to combine VaporVM’s regional cloud and managed-services presence with BIO-key’s authentication technology to support secure, compliant digital transformation.
BIO-key (NASDAQ: BKYI) will showcase passwordless and identity-bound biometric authentication at Africa Tech Festival 2025, Nov 10–13 at the Cape Town International Convention Centre (CTICC), Booth H72. BIO-key and partner Altron Arrow will demonstrate Identity-Bound Biometrics (IBB), the PortalGuard® IAM platform, and Passkey:YOU™ for phoneless, tokenless access.
Visitors can meet the team and view live demonstrations aimed at enabling secure, scalable, and inclusive digital identity solutions for governments and enterprises across Africa.
BIO-key International (NASDAQ: BKYI) will host its Q3 investor call on Friday, November 14, 2025 at 10:00 a.m. ET. The company will release third-quarter results before the market opens that morning.
Chairman & CEO Mike DePasquale and CFO Cecilia Welch will lead the call and a Q&A session. A live webcast and replay will be available, and the audio replay access details are provided for U.S. and international listeners.
Dial-in and webcast details will be available to investors; the webcast replay will remain accessible for three months.
BIO-key (NASDAQ: BKYI) announced a significant deployment with a major Middle East defense-sector security organisation on Nov. 7, 2025.
The solution will protect critical infrastructure and sensitive access environments using BIO-key’s biometric and multi-factor authentication, avoiding reliance on mobile devices or hardware tokens. The customer requested anonymity for security reasons. BIO-key said the contract is one of its largest regional security-sector deployments and follows a new strategic partnership with Cloud Distribution to accelerate in-country delivery and opportunities.
BIO-key (NASDAQ: BKYI) entered into a warrant inducement agreement dated Oct 27, 2025, with an existing institutional investor to induce exercise of Series A and Series B warrants originally issued Jan 15, 2025.
The investor agreed to purchase 3,091,668 shares at a reduced exercise price of $1.02 per share, producing gross proceeds of approximately $3.1 million before placement agent fees and offering expenses. Maxim Group is the exclusive placement agent.
As consideration, BIO-key will issue 6,183,336 unregistered new warrants exercisable at $1.02 per share, immediately exercisable and expiring five years from issuance, and will file an SEC registration statement covering resale of shares issuable on exercise.
BIO-key International (NASDAQ: BKYI) announced a partnership with Scandinavian distributor IT2Trust on October 27, 2025 to expand BIO-key’s identity and access management (IAM) and biometric solutions across Denmark, Sweden, Norway, and Finland.
Under the agreement, IT2Trust will distribute and support BIO-key’s full portfolio including PortalGuard (MFA, SSO), Passkey:YOU (FIDO2 passwordless), PIN:You, WEB-key, Identity-Bound Biometrics, and certified scanners PIV-Pro and EcoID III, with a focus on GDPR compliance and public sector and enterprise adoption.